Literature DB >> 26383047

Complexity and diversity of F8 genetic variations in the 1000 genomes.

J N Li1,2, I G Carrero1,2, J F Dong3,4, F L Yu1,2,5.   

Abstract

BACKGROUND: Hemophilia A (HA) is an X-linked bleeding disorder caused by deleterious mutations in the coagulation factor VIII gene (F8). To date, F8 mutations have been documented predominantly in European subjects and in American subjects of European descent. Information on F8 variants in individuals of more diverse ethnic backgrounds is limited.
OBJECTIVES: To discover novel and rare F8 variants, and to characterize F8 variants in diverse population backgrounds. PATIENTS/
METHODS: We analyzed 2535 subjects, including 26 different ethnicities, whose data were available from the 1000 Genomes Project (1000G) phase 3 dataset, for F8 variants and their potential functional impact.
RESULTS: We identified 3030 single nucleotide variants, 31 short deletions and insertions (Indels) and a large, 497 kb, deletion. Among all variants, 86.4% were rare variants and 55.6% were novel. Eighteen variants previously associated with HA were found in our study. Most of these 'HA variants' were ethnic-specific with low allele frequency; however, one variant (p.M2257V) was present in 27% of African subjects. The p.E132D, p.T281A, p.A303V and p.D422H 'HA variants' were identified only in males. Twelve novel missense variants were predicted to be deleterious. The large deletion was discovered in eight female subjects without affecting F8 transcription and the transcription of genes on the X chromosome.
CONCLUSION: Characterizing F8 in the 1000G project highlighted the complexity of F8 variants and the importance of interrogating genetic variants on multiple ethnic backgrounds for associations with bleeding and thrombosis. The haplotype analysis and the orientation of duplicons that flank the large deletion suggested that the deletion was recurrent and originated by homologous recombination.
© 2015 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  deletion Xq28; ethnic groups; factor VIII; genetic variation; human genome project

Mesh:

Substances:

Year:  2015        PMID: 26383047      PMCID: PMC4928474          DOI: 10.1111/jth.13144

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  33 in total

1.  Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations.

Authors:  Sarah E Flanagan; Ann-Marie Patch; Sian Ellard
Journal:  Genet Test Mol Biomarkers       Date:  2010-08

Review 2.  Toward better understanding of artifacts in variant calling from high-coverage samples.

Authors:  Heng Li
Journal:  Bioinformatics       Date:  2014-06-27       Impact factor: 6.937

3.  Assessing the Disease-Liability of Mutations in CFTR.

Authors:  Claude Ferec; Garry R Cutting
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

4.  Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing.

Authors:  Yali Xue; Yuan Chen; Qasim Ayub; Ni Huang; Edward V Ball; Matthew Mort; Andrew D Phillips; Katy Shaw; Peter D Stenson; David N Cooper; Chris Tyler-Smith
Journal:  Am J Hum Genet       Date:  2012-12-07       Impact factor: 11.025

5.  Eleven novel mutations in the factor VIII gene from Brazilian hemophilia A patients.

Authors:  V R Arruda; W C Pieneman; P H Reitsma; P P Deutz-Terlouw; J M Annichino-Bizzacchi; E Briët; F F Costa
Journal:  Blood       Date:  1995-10-15       Impact factor: 22.113

6.  Int22h-related inversions causing hemophilia A: a novel insight into their origin and a new more discriminant PCR test for their detection.

Authors:  R D Bagnall; F Giannelli; P M Green
Journal:  J Thromb Haemost       Date:  2006-03       Impact factor: 5.824

7.  Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development.

Authors:  Y Repessé; M Slaoui; D Ferrandiz; P Gautier; C Costa; J M Costa; J M Lavergne; A Borel-Derlon
Journal:  J Thromb Haemost       Date:  2007-04-18       Impact factor: 5.824

8.  A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII.

Authors:  Scot A Fahs; Matthew T Hille; Qizhen Shi; Hartmut Weiler; Robert R Montgomery
Journal:  Blood       Date:  2014-04-04       Impact factor: 22.113

9.  Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical application of HRM.

Authors:  Shin-Yu Lin; Yi-Ning Su; Chia-Cheng Hung; Woei Tsay; Shyh-Shin Chiou; Chieh-Ting Chang; Hong-Nerng Ho; Chien-Nan Lee
Journal:  BMC Med Genet       Date:  2008-06-20       Impact factor: 2.103

10.  Transcriptome and genome sequencing uncovers functional variation in humans.

Authors:  Tuuli Lappalainen; Michael Sammeth; Marc R Friedländer; Peter A C 't Hoen; Jean Monlong; Manuel A Rivas; Mar Gonzàlez-Porta; Natalja Kurbatova; Thasso Griebel; Pedro G Ferreira; Matthias Barann; Thomas Wieland; Liliana Greger; Maarten van Iterson; Jonas Almlöf; Paolo Ribeca; Irina Pulyakhina; Daniela Esser; Thomas Giger; Andrew Tikhonov; Marc Sultan; Gabrielle Bertier; Daniel G MacArthur; Monkol Lek; Esther Lizano; Henk P J Buermans; Ismael Padioleau; Thomas Schwarzmayr; Olof Karlberg; Halit Ongen; Helena Kilpinen; Sergi Beltran; Marta Gut; Katja Kahlem; Vyacheslav Amstislavskiy; Oliver Stegle; Matti Pirinen; Stephen B Montgomery; Peter Donnelly; Mark I McCarthy; Paul Flicek; Tim M Strom; Hans Lehrach; Stefan Schreiber; Ralf Sudbrak; Angel Carracedo; Stylianos E Antonarakis; Robert Häsler; Ann-Christine Syvänen; Gert-Jan van Ommen; Alvis Brazma; Thomas Meitinger; Philip Rosenstiel; Roderic Guigó; Ivo G Gut; Xavier Estivill; Emmanouil T Dermitzakis
Journal:  Nature       Date:  2013-09-15       Impact factor: 49.962

View more
  5 in total

1.  Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative.

Authors:  Jill M Johnsen; Shelley N Fletcher; Haley Huston; Sarah Roberge; Beth K Martin; Martin Kircher; Neil C Josephson; Jay Shendure; Sarah Ruuska; Marion A Koerper; Jaime Morales; Glenn F Pierce; Diane J Aschman; Barbara A Konkle
Journal:  Blood Adv       Date:  2017-05-18

Review 2.  Genotypes, phenotypes and whole genome sequence: Approaches from the My Life Our Future haemophilia project.

Authors:  B A Konkle; J M Johnsen; M Wheeler; C Watson; M Skinner; G F Pierce
Journal:  Haemophilia       Date:  2018-05       Impact factor: 4.287

3.  Detection of mosaics in hemophilia A by deep Ion Torrent sequencing and droplet digital PCR.

Authors:  Eric Manderstedt; Rosanna Nilsson; Rolf Ljung; Christina Lind-Halldén; Jan Astermark; Christer Halldén
Journal:  Res Pract Thromb Haemost       Date:  2020-09-07

4.  Determining the impact of uncharacterized inversions in the human genome by droplet digital PCR.

Authors:  Marta Puig; Jon Lerga-Jaso; Carla Giner-Delgado; Sarai Pacheco; David Izquierdo; Alejandra Delprat; Magdalena Gayà-Vidal; Jack F Regan; George Karlin-Neumann; Mario Cáceres
Journal:  Genome Res       Date:  2020-05-18       Impact factor: 9.043

5.  Intronic regions of the human coagulation factor VIII gene harboring transcription factor binding sites with a strong bias towards the short-interspersed elements.

Authors:  Aliakbar Haddad-Mashadrizeh; Jafar Hemmat; Muhammad Aslamkhan
Journal:  Heliyon       Date:  2020-09-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.